Rapid communication: Enalapril decreases nuclear factor κB activation in the kidney with ureteral obstruction

Kidney International

Volumn 52, Issue 4, 1997, Pages 926-933

  Morrissey, Jeremiah J ^a   Klahr, Saulo ^a  

^a BARNES JEWISH HOSPITAL   (United States)

Author keywords

ACE inhibition; DNA binding protein; Enalapril; Inflammation; Nuclear factor B; Obstruction; Transcription factors

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DRINKING WATER; ENALAPRIL; INTERCELLULAR ADHESION MOLECULE 1; NUCLEAR FACTOR; TRANSCRIPTION FACTOR; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTERIOSCLEROSIS; ARTICLE; DIABETIC NEPHROPATHY; ENZYME ACTIVATION; ENZYME ACTIVITY; FEMALE; IMMUNOCYTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; RAT; TREATMENT PLANNING; URETER OBSTRUCTION;

EID: 0030768884     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1997.414     Document Type: Article

References (36)

1. EDDY AA, MICHAEL AF: Acute tubulointerstitial nephritis associated with aminonucleoside nephrosis. Kidney Int 33:14-23, 1998
2. GHILLUM DM, TRUONG L, TASBY J: Characterization of the interstitial cellular infiltrate in experimental chronic cyclosporine nephropathy. Transplantation 49:793-797, 1990
3. PESEK-DIAMOND I, DING G, FRYE J, DIAMOND JR: Macrophages mediate adverse effects of cholesterol feeding in experimental nephrosis. Am J Physiol 263:F776-F783, 1992
4. SCHREINER GF, HARRIS KPG, PURKERSON ML, KLAHR S: Immunological aspects of acute ureteral obstruction: Immune cell infiltrate in the kidney. Kidney Int 34:487-493, 1988
5. TRUONG LD, FARHOOD A, TASBY J, GILLUM D: Experimental chronic renal ischemia: Morphologic and immunologic studies. Kidney Int 41:1676-1689, 1992
6. EDDY AA: Interstitial nephritis induced by protein-overload protein-uria. Am J Pathol 135:719-733, 1989
7. TANAKA K, OKUDA S, ANDO T, IWAMOTO T, NAKAYAMA M, FUJISHIMA M: TGF-β1 in glomerulosclerosis and interstitial fibrosis of adriamycin nephropathy. Kidney Int 45:525-536, 1994
8. YOUNG BA, JOHNSON RJ, ALPERS CE, ENG E, GORDON K, FLOEGE J, COUSER WG: Cellular events in the evolution of experimental diabetic nephropathy. Kidney Int 47:935-944, 1995
9. LEFKOWITH JB, SCHREINER G: Essential fatty acid deficiency depletes rat glomeruli of resident macrophages and inhibits angiotensin II-induced eicosanoid synthesis. J Clin Invest 80:947-956, 1987
10. DIAMOND JR, PESEK-DIAMOND I: Sublethal X-irradiation during acute puromycin nephrosis prevents late renal injury: Role of glomerular and interstitial macrophages. Am J Physiol 260:F779-F786, 1991
11. MODI KS, MORRISSEY J, SHAH SV, SCHREINER GF, KLAHR S: Effects of probucol on renal function in rats with bilateral ureteral obstruction. Kidney Int 38:843-850, 1990
12. KANETO H, MORRISSEY J, MCCRACKEN R, REYES A, KLAHR S: Enalapril reduces collagen type IV synthesis and expansion of the interstitium in the obstructed kidney of the rat. Kidney Int 45:1637-1647, 1994
13. REYES AA, PORRAS BH, CHASALOW FI, KLAHR S: L-arginine decreases the infiltration of the kidney by macrophages in obstructive nephropathy and puromycin-induced nephrosis. Kidney Int 45:1346-1354, 1994
14. MORRISSEY JJ, ISHIDOYA S, MCCRACKEN R, KLAHR S: Nitric oxide generation ameliorates the tubulointerstitial fibrosis of obstructive nephropathy. J Am Soc Nephrol 7:2202-2212, 1996
15. BRADY HR: Leukocyte adhesion molecules and kidney diseases. Kidney Int 45:1285-1300, 1994
16. RICARDO SD, LEVINSON ME, DEJOSEPH MR, DIAMOND JR: Expression of adhesion molecules in rat renal cortex during experimental hydronephrosis. Kidney Int 50:2002-2010, 1996
17. DUAN L, MORRISSEY J, MCCRACKEN R, KLAHR S: Regulation of MCP-1. ICAM-1and VCAM-1 during unilateral ureteral obstruction. (abstract) J Am Soc Nephrol 7:1697, 1996
18. COLLINS T: Endothelial nuclear factor-κB and the initiation of the atherosclerotic lesion. Lab Invest 68:499-508, 1993
19. BAEUERLE PA, HENKEL T: Function and activation of NF-κB in the immune system. Annu Rev Immunol 12:141-179, 1994
20. WENDT T, ZHANG YM, BIERHAUS A, KRIEGSMANN J, DENG Y, WALDHERR R, TESKE T, LUTHER T, FÜNFSTÜCK R, NAWROTH PP, STEIN G: Tissue factor expression in an animal model of hydronephrosis. Nephrol Dial Transplant 10:1820-1828, 1995
21. HERNÁNDEZ-PRESA M, BUSTOS C, ORTEGO M, TUÑON J, RENEDO G, RUIZ-ORGETA M, EGIDO J: Angiotensin-converting enzyme inhibition prevents arterial nuclear factor-κB activation, monocyte chemoattractant protein-1 expression, and macrophage infiltration in a rabbit model of early accelerated atherosclerosis. Circulation 95:1532-1541, 1997
22. ZEIHER AM, FISSLTHALER B, SCHRAY-UTZ B, BUSSE R: Nitric oxide modulates the expression of monocyte chemoattractant protein 1 in cultured human endothelial cells. Circ Res 76:980-986, 1995
23. WU H, LOZANO G: NF-κB activation of p53; a potential mechanism for suppressing cell growth in response to stress. J Biol Chem 31:20067-20074, 1994
24. LEE SOO YOUNG, LEE SANGYULL, KANDALA G, LIOU M-L, LIOU H-C, CHOI Y: CD30/TNF receptor-associated factor interaction: NF-κB activation and binding specificity. Proc Natl Acad Sci USA 93:9699-9703, 1996
25. NAGLE RB, KNEISER MR, BULGER RE, BENDITT EP: Induction of smooth muscle characteristics in renal interstitial fibroblasts during obstructive nephropathy. Lab Invest 29:422-427, 1973
26. DIAMOND JR, VAN GOOR H, DING G, ENGLEMYER E: Myofibroblasts in experimental hydronephrosis. Am J Pathol 146:121-129, 1995
27. SKIDGEL RA, ENGELBRECHT S, JOHNSON AR, ERDOS EG: Hydrolysis of substance p and neurotensin by converting enzyme and neutral endopeptidase. Peptides 5:769-776, 1984
28. PAN ZK, ZURAW BL, LUNG C-C, PROSSNITZ ER, BROWNING DD, YE RD: Bradykinin stimulates NF-κB activation and interleukin 1β gene expression in cultured human fibroblasts. J Clin Invest 98:2042-2049, 1996
29. DE CATERINA R, LIBBY P, PENG H-B, THANNICKAL VJ, RAJAVASHISTH TB, GIMBRONE MA JR. SHIN WS, LIAO JK: Nitric oxide decreases cytokine-induced endothelial activation; nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest 96:60-68, 1995
30. LEHMING N, THANOS D, BRICKMAN JM, MA J, MANIATIS T, PTASHNE M: An HMG-like protein that can switch a transcriptional activator to a repressor. Nature 371:175-179, 1994
31. LECLAIR KP, BLANAR MA, SHARP PA: The p50 subunit of NF-κB associates with the NF-IL6 transcription factor. Proc Natl Acad Sci USA 89:8145-8149, 1992
32. TAMAMI M, LINDHOLM PF, BRADY JN: The retinoblastoma gene product (Rb) induces binding of a conformationally inactive nuclear factor-κB. J Biol Chem 271:24551-24556, 1996
33. HARANT H, DE MARTIN R, ANDREW PJ, FOGLAR E, DITTRICH C, LINDLEY IJD: Synergistic activation of interleukin-8 gene transcription by AII-trans-retinoic acid and tumor necrosis factor-α involves the transcription factor NF-κB. J Biol Chem 271:26954-26961, 1996
34. MIN W, GHOSH S, LENGYEL P: The interferon-inducible p202 protein as a modulator of transcription: Inhibition of NF-κB, c-Fos, and c-Jun activities. Mol Cell Biol 16:359-368, 1996
35. PERKINS ND, FELZIEN LK, BETTS JC, LEUNG K, BEACH DH, NABEL GJ: Regulation of NF-κB by cyclin-dependent kinases associated with the p300 coactivator. Science 275:523-527, 1997
36. ADAMS BS, LEUNG K, HANLEY EW, NABEL GJ: Cloning of RκB, a novel DNA-binding protein that recognizes the interleukin-2 receptor a chain KB site. New Biologist 3:1063-1073, 1991